Vanberra Signal
Teligenz logo

Teligenz

Curated by Signal

Trade life cycle management solutions empowering equity investors and brokers.

Overview

Teligenz is a company that specializes in trade life cycle management, offering solutions that cover all phases of a trade, from initiation to settlement. Their product offerings include Hypertrade, Hypersync, and LinkedEye, which are designed for brokers and individual investors, with a particular focus on equity investment in India. The company integrates automation and real-time processing capabilities to reduce manual intervention and improve operational efficiency. Teligenz aims to assist individuals in managing market risks. The team at Teligenz has experience in capital markets technology and provides tools that facilitate compliance and informed decision-making, addressing the complexities associated with capital markets.

Key facts

Founded
2013
Headquarters
Bengaluru, India

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Investment Technology companies
  • Trade life cycle management platform optimizing structured product distribution.

    Investment TechnologyLondon, United Kingdom
  • Trade life cycle management platform enhancing developer productivity in finance.

    Investment TechnologyNew York City, United States
  • Trade life cycle management platform enhancing investment processes for managers.

    Investment TechnologyGlasgow, United Kingdom
+ 461 more similar companies on Signal

About Teligenz

What does Teligenz do?

Teligenz is a company that specializes in trade life cycle management, offering solutions that cover all phases of a trade, from initiation to settlement.

Where is Teligenz headquartered?

Teligenz is headquartered in Bengaluru, India.

When was Teligenz founded?

Teligenz was founded in 2013.

Which sector is Teligenz in?

Teligenz operates in Investment Technology, part of Financial Technology.

Who are Teligenz's competitors?

Companies similar to Teligenz include IVM, Velox, and Asurafin.